{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ONE&page=71", "query": { "intervention": "ONE", "page": 71 }, "page_size": 10 }, "pagination": { "page": 71, "page_size": 10, "total_count": 2136, "total_pages": 214, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ONE&page=72&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ONE&page=70&page_size=10" }, "source": "local", "last_synced_at": "2026-10-19T06:15:43.206Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05282550", "title": "Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "AMCI - Amnestic Mild Cognitive Impairment", "Sleep Disturbance" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Trazodone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 100, "start_date": "2023-02-02", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-10-15T02:40:51.093Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05282550" }, { "nct_id": "NCT04083183", "title": "Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Non-Malignant Neoplasm" ], "interventions": [ { "name": "Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10", "type": "BIOLOGICAL" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Hematopoietic Cell Transplantation", "type": "PROCEDURE" }, { "name": "Lapine T-Lymphocyte Immune Globulin", "type": "BIOLOGICAL" }, { "name": "Mycophenolate Mofetil", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" }, { "name": "Total-Body Irradiation", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "DRUG", "RADIATION" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 40, "start_date": "2020-06-16", "completion_date": "2028-01-09", "has_results": false, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-07-30T07:46:43.380Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04083183" }, { "nct_id": "NCT05734625", "title": "Efficacy of Nerve Blocks for Episodic Migraine", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Episodic Migraine" ], "interventions": [ { "name": "Bupivacaine HCl 0.5% Injectable Solution", "type": "DRUG" }, { "name": "Methylprednisolone 40 MG Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2023-07-10", "completion_date": "2027-07", "has_results": false, "last_update_posted_date": "2026-06-16", "last_synced_at": "2026-08-02T07:52:58.317Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05734625" }, { "nct_id": "NCT07547215", "title": "Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroiliac Joint Fusion", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sacroiliac Joint Dysfunction", "Sacroiliac Joint Pain" ], "interventions": [ { "name": "Bone Allograft", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "PainTEQ, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 100, "start_date": "2026-05-27", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-08-06T10:02:34.948Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07547215" }, { "nct_id": "NCT06447103", "title": "An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Clear Cell Renal Cell Carcinoma", "Sarcomatoid Renal Cell Carcinoma", "Stage II Renal Cell Cancer", "Stage III Renal Cell Cancer", "Stage IV Renal Cell Cancer" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Scan", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Zirconium Zr 89 Girentuximab", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "OTHER", "DRUG" ], "sponsor": "Jonsson Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 91, "start_date": "2024-08-06", "completion_date": "2030-12-01", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-10-15T20:07:33.417Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06447103" }, { "nct_id": "NCT05422911", "title": "Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Castrate-sensitive", "Castrate-sensitive Prostate Cancer", "Metastatic Cancer", "Neoplasm, Prostate" ], "interventions": [ { "name": "Abiraterone acetate", "type": "DRUG" }, { "name": "Apalutamide", "type": "DRUG" }, { "name": "Enzalutamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sun Pharmaceutical Industries Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 192, "start_date": "2022-08-31", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-10-06T00:37:58.988Z", "location_count": 12, "location_summary": "Los Angeles, California • Tampa, Florida • Ann Arbor, Michigan + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05422911" }, { "nct_id": "NCT07336368", "title": "Topical Cryotherapy and Keloid/Hypertrophic Scars", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertrophic Scars", "Keloid Scars" ], "interventions": [ { "name": "Cryotherapy with liquid nitrogen", "type": "DEVICE" }, { "name": "Intralesional Triamcinolone 10 mg/ml", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Sonal Choudhary", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2026-06-10", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-06-12", "last_synced_at": "2026-10-16T18:05:45.130Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07336368" }, { "nct_id": "NCT06439524", "title": "The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Endometriosis" ], "interventions": [ { "name": "40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Main Line Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 110, "start_date": "2024-08-15", "completion_date": "2028-12-01", "has_results": false, "last_update_posted_date": "2026-06-12", "last_synced_at": "2026-10-17T04:12:33.049Z", "location_count": 1, "location_summary": "Wynnewood, Pennsylvania", "locations": [ { "city": "Wynnewood", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06439524" }, { "nct_id": "NCT06342375", "title": "Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "No Medicaid Coverage" ], "interventions": [ { "name": "Outbound phone call", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 230000, "start_date": "2025-02-12", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-06-12", "last_synced_at": "2026-08-06T11:47:27.282Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06342375" }, { "nct_id": "NCT05880914", "title": "Precision Medicine Approaches to Renal Osteodystrophy", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bone Turnover Rate Disorder", "CKD-MBD", "Chronic Kidney Diseases", "Renal Osteodystrophy", "Secondary Hyperparathyroidism" ], "interventions": [ { "name": "Standard treatment for bone disorder", "type": "DRUG" }, { "name": "miRNAseq analysis", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Thomas Nickolas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2022-12-21", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-06-12", "last_synced_at": "2026-10-19T06:15:43.206Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05880914" } ] }